JP2022526267A5 - - Google Patents
Info
- Publication number
- JP2022526267A5 JP2022526267A5 JP2021555448A JP2021555448A JP2022526267A5 JP 2022526267 A5 JP2022526267 A5 JP 2022526267A5 JP 2021555448 A JP2021555448 A JP 2021555448A JP 2021555448 A JP2021555448 A JP 2021555448A JP 2022526267 A5 JP2022526267 A5 JP 2022526267A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- modified oligonucleotide
- composition according
- pbs
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024168231A JP2025000805A (ja) | 2019-03-15 | 2024-09-27 | ｋｃｎｔ１発現を低減するための化合物及び方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819344P | 2019-03-15 | 2019-03-15 | |
| US62/819,344 | 2019-03-15 | ||
| US201962884501P | 2019-08-08 | 2019-08-08 | |
| US62/884,501 | 2019-08-08 | ||
| PCT/US2020/022680 WO2020190740A1 (en) | 2019-03-15 | 2020-03-13 | Compounds and methods for reducing kcnt1 expression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024168231A Division JP2025000805A (ja) | 2019-03-15 | 2024-09-27 | ｋｃｎｔ１発現を低減するための化合物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526267A JP2022526267A (ja) | 2022-05-24 |
| JP2022526267A5 true JP2022526267A5 (cg-RX-API-DMAC7.html) | 2023-08-24 |
| JP7564817B2 JP7564817B2 (ja) | 2024-10-09 |
Family
ID=72520445
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555448A Active JP7564817B2 (ja) | 2019-03-15 | 2020-03-13 | ｋｃｎｔ１発現を低減するための化合物及び方法 |
| JP2024168231A Pending JP2025000805A (ja) | 2019-03-15 | 2024-09-27 | ｋｃｎｔ１発現を低減するための化合物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024168231A Pending JP2025000805A (ja) | 2019-03-15 | 2024-09-27 | ｋｃｎｔ１発現を低減するための化合物及び方法 |
Country Status (19)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202001685TA (en) | 2017-08-28 | 2020-03-30 | Enanta Pharm Inc | Hepatitis b antiviral agents |
| IL283190B2 (en) | 2018-11-21 | 2025-08-01 | Enanta Pharm Inc | Functionalized heterocycles as antiviral agents |
| WO2021188414A1 (en) | 2020-03-16 | 2021-09-23 | Enanta Pharmaceuticals, Inc. | Functionalized heterocyclic compounds as antiviral agents |
| EP4441229A1 (en) * | 2021-12-01 | 2024-10-09 | Atalanta Therapeutics, Inc. | Compositions and methods for treatment of epilepsies |
| IL326478A (en) * | 2023-08-16 | 2026-04-01 | Servier Lab | Oligonucleotides for modulation of KCNT1 expression |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050288242A1 (en) * | 2001-05-18 | 2005-12-29 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA) |
| US7601501B2 (en) | 2006-08-11 | 2009-10-13 | The Scripps Research Institute | Controlling osteogenesis by inhibition of osteogenic suppressors |
| CA2817256A1 (en) * | 2010-11-12 | 2012-05-18 | The General Hospital Corporation | Polycomb-associated non-coding rnas |
| TW202246503A (zh) | 2013-07-19 | 2022-12-01 | 美商百健Ｍａ公司 | 用於調節τ蛋白表現之組合物 |
| US20200129538A1 (en) * | 2017-06-13 | 2020-04-30 | The Florey Institute Of Neuroscience And Mental Health | Compositions and methods for treating conditions associated with gain-of-function mutations in kcnt1 |
-
2020
- 2020-03-13 CR CR20210519A patent/CR20210519A/es unknown
- 2020-03-13 PH PH1/2021/552220A patent/PH12021552220A1/en unknown
- 2020-03-13 EP EP20773689.3A patent/EP3938514A4/en active Pending
- 2020-03-13 US US17/437,507 patent/US20220177893A1/en not_active Abandoned
- 2020-03-13 CN CN202080020884.0A patent/CN113661241A/zh active Pending
- 2020-03-13 JP JP2021555448A patent/JP7564817B2/ja active Active
- 2020-03-13 CN CN202511762645.3A patent/CN121674396A/zh active Pending
- 2020-03-13 CN CN202311150264.0A patent/CN117106778A/zh active Pending
- 2020-03-13 AU AU2020241693A patent/AU2020241693B2/en not_active Ceased
- 2020-03-13 CA CA3133247A patent/CA3133247A1/en active Pending
- 2020-03-13 SG SG11202108625WA patent/SG11202108625WA/en unknown
- 2020-03-13 MX MX2021011132A patent/MX2021011132A/es unknown
- 2020-03-13 BR BR112021015494-9A patent/BR112021015494A2/pt unknown
- 2020-03-13 PE PE2021001518A patent/PE20220168A1/es unknown
- 2020-03-13 WO PCT/US2020/022680 patent/WO2020190740A1/en not_active Ceased
- 2020-03-13 KR KR1020217032716A patent/KR20210141983A/ko not_active Withdrawn
- 2020-03-16 TW TW109108639A patent/TW202102675A/zh unknown
-
2021
- 2021-08-11 IL IL285546A patent/IL285546A/en unknown
- 2021-09-14 CL CL2021002398A patent/CL2021002398A1/es unknown
- 2021-09-14 JO JOP/2021/0254A patent/JOP20210254A1/ar unknown
- 2021-10-06 CO CONC2021/0013371A patent/CO2021013371A2/es unknown
-
2024
- 2024-09-27 JP JP2024168231A patent/JP2025000805A/ja active Pending
-
2025
- 2025-06-27 US US19/252,993 patent/US20250320505A1/en active Pending